GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indoco Remedies Ltd (BOM:532612) » Definitions » Price-to-Owner-Earnings

Indoco Remedies (BOM:532612) Price-to-Owner-Earnings : (As of May. 31, 2025)


View and export this data going back to 2005. Start your Free Trial

What is Indoco Remedies Price-to-Owner-Earnings?

As of today (2025-05-31), Indoco Remedies's share price is ₹250.30. Indoco Remedies does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Indoco Remedies's Price-to-Owner-Earnings or its related term are showing as below:

During the past 13 years, the highest Price-to-Owner-Earnings of Indoco Remedies was 75.48. The lowest was 28.44. And the median was 44.20.


BOM:532612's Price-to-Owner-Earnings is not ranked *
in the Drug Manufacturers industry.
Industry Median: 25.25
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2025-05-31), Indoco Remedies's share price is ₹250.30. Indoco Remedies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ₹-8.41. Therefore, Indoco Remedies's PE Ratio (TTM) for today is At Loss.

As of today (2025-05-31), Indoco Remedies's share price is ₹250.30. Indoco Remedies's EPS without NRI for the trailing twelve months (TTM) ended in was ₹-8.51. Therefore, Indoco Remedies's PE Ratio without NRI for today is At Loss.

During the past 13 years, Indoco Remedies's highest PE Ratio without NRI was 173.13. The lowest was 0.00. And the median was 54.25.


Indoco Remedies Price-to-Owner-Earnings Historical Data

The historical data trend for Indoco Remedies's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indoco Remedies Price-to-Owner-Earnings Chart

Indoco Remedies Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 58.19 40.40 70.86 -

Indoco Remedies Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 70.86 - - - -

Competitive Comparison of Indoco Remedies's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Indoco Remedies's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Indoco Remedies's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Indoco Remedies's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Indoco Remedies's Price-to-Owner-Earnings falls into.


;
;

Indoco Remedies Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Indoco Remedies's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=250.30/-13.03
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Indoco Remedies  (BOM:532612) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Indoco Remedies Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Indoco Remedies's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Indoco Remedies Business Description

Traded in Other Exchanges
Address
166 CST Road, Indoco House, Kalina, Santacruz (East), Mumbai, MH, IND, 400 098
Indoco Remedies Ltd is an India-based pharmaceutical company. The company is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The company manufactures products for different therapeutic sectors including Gastroenterology, Dentistry & Stomatology, Respiratory, Diabetology, Women's Health, Nutritional products, Cardiology, Metabolic Disorders, and Primary Care medicines. The only operating segment of the company is Pharmaceutical Products. Geographically, it generates the majority of the revenue from India.

Indoco Remedies Headlines

No Headlines